Literature DB >> 9119466

Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: effects of interleukin-12.

K Kawakami1, M Tohyama, X Qifeng, A Saito.   

Abstract

We have recently established a murine model of pulmonary and disseminated infection with a highly virulent strain of Cryptococcus neoformans and demonstrated that administration of interleukin-12 (IL-12) protected the animals against infection. In this study, we extended these studies by investigating the host defense mechanisms. In particular, we examined the expression of mRNA for helper T-cell 1 (Th1) cytokines (IL-2, lymphotoxin, and gamma interferon [IFN-gamma]), Th2 cytokines (IL-4, -6, and -10), macrophage-derived cytokines (tumor necrosis factor alpha [TNF-alpha], IL-1beta, transforming growth factor beta [TGF-beta, IL-12p40, and IFN-gamma-inducing factor [IGIF]), and inducible nitric oxide synthase (iNOS) in the lungs on days 1, 3, 7, and 14 after infection and following treatment with IL-12. There was little or no expression of mRNAs for Th1 cytokines, TNF-alpha, IL-12p40, IGIF, and iNOS in the infected mice, but expression increased markedly after treatment with IL-12. In contrast, the mRNAs for Th2 cytokines, IL-1beta, and TGF-beta were detected at considerable levels during the early stages of infection, and, interestingly, expression was not suppressed by IL-12 but rather augmented, particularly during the late stage. Similar results were also obtained for IFN-gamma, IL-4, IL-10, and TNF-alpha measured in the lung homogenates by enzyme-linked immunosorbent assay. These results suggest that the predominance of expression of Th2 cytokines and TGF-beta over Th1 cytokines, TNF-alpha, IL-12p40, IGIF, and iNOS is associated with severe lethal infection in mice and that administration of IL-12 protects infected animals by stimulating Th1 cytokines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9119466      PMCID: PMC175132          DOI: 10.1128/iai.65.4.1307-1312.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  51 in total

1.  Activation of gamma delta T cells for production of IFN-gamma is mediated by bacteria via macrophage-derived cytokines IL-1 and IL-12.

Authors:  M J Skeen; H K Ziegler
Journal:  J Immunol       Date:  1995-06-01       Impact factor: 5.422

Review 2.  Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity.

Authors:  G Trinchieri
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

3.  IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses.

Authors:  L Meyaard; E Hovenkamp; S A Otto; F Miedema
Journal:  J Immunol       Date:  1996-04-15       Impact factor: 5.422

4.  IL-12 exacerbates rather than suppresses T helper 2-dependent pathology in the absence of endogenous IFN-gamma.

Authors:  T A Wynn; D Jankovic; S Hieny; K Zioncheck; P Jardieu; A W Cheever; A Sher
Journal:  J Immunol       Date:  1995-04-15       Impact factor: 5.422

5.  IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis.

Authors:  L Romani; A Mencacci; L Tonnetti; R Spaccapelo; E Cenci; P Puccetti; S F Wolf; F Bistoni
Journal:  J Immunol       Date:  1994-12-01       Impact factor: 5.422

6.  Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia.

Authors:  A Marchant; C Bruyns; P Vandenabeele; M Ducarme; C Gérard; A Delvaux; D De Groote; D Abramowicz; T Velu; M Goldman
Journal:  Eur J Immunol       Date:  1994-05       Impact factor: 5.532

7.  Interferon gamma-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major.

Authors:  Z E Wang; S Zheng; D B Corry; D K Dalton; R A Seder; S L Reiner; R M Locksley
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

8.  Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii.

Authors:  R T Gazzinelli; M Wysocka; S Hayashi; E Y Denkers; S Hieny; P Caspar; G Trinchieri; A Sher
Journal:  J Immunol       Date:  1994-09-15       Impact factor: 5.422

9.  Transforming growth factor-beta inhibits interleukin-12-induced production of interferon-gamma by natural killer cells: a role for transforming growth factor-beta in the regulation of T cell-independent resistance to Toxoplasma gondii.

Authors:  C A Hunter; L Bermudez; H Beernink; W Waegell; J S Remington
Journal:  Eur J Immunol       Date:  1995-04       Impact factor: 5.532

10.  Interleukin-10 downregulates protective immunity to Brucella abortus.

Authors:  D M Fernandes; C L Baldwin
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

View more
  32 in total

1.  Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection.

Authors:  Amy C Herring; John Lee; Roderick A McDonald; Galen B Toews; Gary B Huffnagle
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

2.  Presentation of cryptococcal capsular polysaccharide (GXM) on activated antigen-presenting cells inhibits the T-suppressor response and enhances delayed-type hypersensitivity and survival.

Authors:  R Blackstock; A Casadevall
Journal:  Immunology       Date:  1997-11       Impact factor: 7.397

3.  Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans.

Authors:  C Retini; T R Kozel; D Pietrella; C Monari; F Bistoni; A Vecchiarelli
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

4.  Regulatory effects of macrophage inflammatory protein 1alpha/CCL3 on the development of immunity to Cryptococcus neoformans depend on expression of early inflammatory cytokines.

Authors:  M A Olszewski; G B Huffnagle; T R Traynor; R A McDonald; D N Cook; G B Toews
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

5.  Progress Toward a Human Vaccine Against Coccidioidomycosis.

Authors:  Garry T Cole; Brady J Hurtgen; Chiung-Yu Hung
Journal:  Curr Fungal Infect Rep       Date:  2012-12-01

6.  Involvement of CD14, toll-like receptors 2 and 4, and MyD88 in the host response to the fungal pathogen Cryptococcus neoformans in vivo.

Authors:  Lauren E Yauch; Michael K Mansour; Shmuel Shoham; James B Rottman; Stuart M Levitz
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

7.  Differential activation of peritoneal cells by subcutaneous treatment of rats with cryptococcal antigens.

Authors:  José L Baronetti; Laura S Chiapello; Ana P Garro; Diana T Masih
Journal:  Clin Vaccine Immunol       Date:  2009-06-03

Review 8.  Role of dendritic cell-pathogen interactions in the immune response to pulmonary cryptococcal infection.

Authors:  Alison J Eastman; John J Osterholzer; Michal A Olszewski
Journal:  Future Microbiol       Date:  2015       Impact factor: 3.165

9.  Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitis.

Authors:  A Ukil; S Maity; S Karmakar; N Datta; J R Vedasiromoni; Pijush K Das
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

10.  Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis.

Authors:  Karen L Wozniak; Sailatha Ravi; Sandra Macias; Mattie L Young; Michal A Olszewski; Chad Steele; Floyd L Wormley
Journal:  PLoS One       Date:  2009-09-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.